All results

61 results

• A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease

  This research study is for individuals who have inflammatory bowel disease (IBD), including Crohn’s disease (CD), ulcerative colitis (UC), and Indeterminate…

  Ages

  2 Years - 75 Years

  Sexes

  All

• A 5-year Longitudinal Observational Study of Patients with Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)

  This is an observational research study. Individuals are being asked to be a part of this study because they have non-alcoholic fatty liver disease (NAFLD).…

  Ages

  2 Years - 75 Years

  Sexes

  All

• A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Outpatient, Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older with Stereotypical Prolonged Seizures

  Study EP0162 is a double-blind, randomized, placebo-controlled, multi-center, parallel-group, Phase 3 study to investigate the efficacy and safety of Staccato…

  Ages

  12 Years - N/A

  Sexes

  All

• A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein (a) (20226313)

  This study is being done to learn more about olpasiran (AMG 890) in people with cardiovascular disease and elevated Lp(a). It will see if olpasiran (AMG 890)…

  Ages

  18 Years - 85 Years

  Sexes

  All

• A Multicenter, Interventional, Retrospective and Prospective study of Enzyme Replacement Therapy (VPRIV) Clinical Outcomes and Safety in Gaucher Disease Type 1 Patients Previously Treated with Substrate Reduction Therapy

  Adult patients with Gaucher Disease Type 1 who have previously received SRT (substrate replacement therapy) and are now receiving ERT (enzyme replacement…

  Ages

  N/A

  Sexes

  All

• A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Trial to Evaluate the Effect of In-Hospital Initiation of Dapagliflozin on Clinical Outcomes in Patients with Heart Failure with Reduced Ejection Fraction Who Have Been Stabilized

  This study will test whether the drug dapagliflozin is safe and has beneficial effects when added to conventional heart failure therapy in patients who have…

  Ages

  18 Years - N/A

  Sexes

  All

• A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Investigate the Efficacy and Safety of Asapiprant in Hospitalized Adults With COVID-19

  Individuals diagnosed with COVID-19 are being asked to take part in a research study of an investigational drug called Asapiprant (BGE 175). This drug is being…

  Ages

  N/A

  Sexes

  All

• A Phase 1b/2 Study of CPI-1205, a Small Molecule Inhibitor of EZH2, Combined with Enzalutamide or Abiraterone/Prednisone in Patients with Metastatic Castration

  The purpose of this study is to see if the drug, CPI-1205, in combination with standard of care treatments enzalutamide or abiraterone/prednisone can improve…

  Ages

  18 Years - 75 Years

  Sexes

  All

• A Phase 2, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Omadacycline in Adult Subjects with Nontuberculous Mycobacterial (NTM) Pulmonary Disease Caused by

  This study is investigating the efficacy, safety, and tolerability, of an antibiotic medication called omadacycline in adult subjects with Nontuberculous…

  Ages

  18 Years - 100 Years

  Sexes

  All

• A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Range Finding Clinical Trial to Evaluate the Tolerability, Safety, and Efficacy of PRAX-944 in the Treatment of Adults with Essential Tremor

  This multi-center, randomized, double-blind, placebo-controlled, dose-range-finding clinical trial will assess the efficacy, safety, and tolerability of…

  Ages

  N/A

  Sexes

  All